Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Somahlution
Jupiter, Florida, United Statessomahlution.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
DuraGraft has demonstrated efficacy in protecting vascular graft integrity during bypass surgeries leading to reduced rates of myocardial infarction, repeat revascularization procedures, and other major adverse cardiac events associated with graft failure[3][5][7]. It is currently commercially available in Europe while US regulatory approval processes are ongoing under new ownership[5].
- Therapeutic areas
- Cardiovascular
- Modalities
- Medical device/preservation solution (DuraGraft)Clinical research services supporting vascular grafting procedures
- Industry
- Surgical Medical Devices
02
Partnerships
Distribution agreement with Marizyme for South America & Mexicomanufacturing agreement with BioLife Solutions previously
Beyond the preview
Go deeper on Somahlution.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Somahlution.